{"transactions":[{"id":738461,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true}}],"security":"Stock Tracking Unit","published_at":"2026-06-15T21:02:04.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each stock tracking unit (\"STU\") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant."}],"balance_after":8325,"derivative":{"underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0001437749-26-020676","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926020676/rdgdoc.xml","form_type":"4"}},{"id":740143,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T20:12:38.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 35,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the Company's Board of Directors on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock."}],"balance_after":168140,"source":{"system":"sec-edgar","filing":"0001104659-26-073461","document":"tm2617536-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926073461/tm2617536-4_4seq1.xml","form_type":"4"}},{"id":1110358,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T21:46:18.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":14718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":279653,"source":{"system":"sec-edgar","filing":"0001437749-25-020543","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925020543/rdgdoc.xml","form_type":"4"}},{"id":1113684,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:30:14.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the Company's Board of Directors on such dates."}],"balance_after":133140,"source":{"system":"sec-edgar","filing":"0001104659-25-058915","document":"tm2517867-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925058915/tm2517867-1_4seq1.xml","form_type":"4"}},{"id":1473836,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-20T22:05:55.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":22250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":264935,"source":{"system":"sec-edgar","filing":"0001437749-24-020849","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924020849/rdgdoc.xml","form_type":"4"}},{"id":1480901,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T20:22:01.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the board on such dates."}],"balance_after":103140,"source":{"system":"sec-edgar","filing":"0001104659-24-071285","document":"tm2416958-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924071285/tm2416958-2_4seq1.xml","form_type":"4"}},{"id":1771751,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T21:01:00.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":242685,"source":{"system":"sec-edgar","filing":"0001104659-23-105394","document":"tm2327273-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923105394/tm2327273-3_4seq1.xml","form_type":"4"}},{"id":1849947,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T12:15:07.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the board on such dates."}],"balance_after":73140,"source":{"system":"sec-edgar","filing":"0001104659-23-072605","document":"tm2319007-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923072605/tm2319007-1_4seq1.xml","form_type":"4"}},{"id":2203526,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T20:31:41.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":43732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":222685,"source":{"system":"sec-edgar","filing":"0001104659-22-082020","document":"tm2221660-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082020/tm2221660-3_4seq1.xml","form_type":"4"}},{"id":2270552,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T12:33:45.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":6000,"price":17.4,"value":104400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $17.16 to $17.66. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":55140,"source":{"system":"sec-edgar","filing":"0001104659-22-060913","document":"tm2215423-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922060913/tm2215423-3_4seq1.xml","form_type":"4"}},{"id":2305008,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-04-05T20:47:57.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025."}],"balance_after":15000,"derivative":{"exercise_price":7.02,"exercise_date":"2023-04-01","expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-042820","document":"tm2211420-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922042820/tm2211420-5_4seq1.xml","form_type":"4"}},{"id":2659483,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:25:50.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 18, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":178953,"source":{"system":"sec-edgar","filing":"0001104659-21-084258","document":"tm2120405-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084258/tm2120405-3_4seq1.xml","form_type":"4"}},{"id":3101200,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-24T23:50:21.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 22, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":158953,"source":{"system":"sec-edgar","filing":"0001104659-20-076545","document":"tm2022959-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/tm2022959-4_4.xml","form_type":"4"}},{"id":3114505,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-10T11:18:03.000Z","date":"2020-06-10","kind":"disposition_to_issuer","acquired":false,"shares":44058,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of under the Merger Agreement in exchange for the excess of the Offer Price over the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All options were vested and exercisable as of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":4.12,"expiration_date":"2026-02-24","underlying":"Common Stock","underlying_shares":44058},"source":{"system":"sec-edgar","filing":"0001104659-20-071835","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920071835/a4.xml","form_type":"4"}},{"id":3114504,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-10T11:18:03.000Z","date":"2020-06-10","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of under the Merger Agreement in exchange for the excess of the Offer Price over the exercise price of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All options were vested and exercisable as of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":5.77,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-071835","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920071835/a4.xml","form_type":"4"}},{"id":3114503,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-06-10T11:18:03.000Z","date":"2020-06-10","kind":"other","acquired":false,"shares":1374352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of in connection with a tender offer made pursuant to the Merger Agreement, in exchange for $11.50 per share, net to the holder in cash, plus one contractual contingent value right (\"CVR\") per share (collectively, the \"Offer Price\").  Each CVR represents the right to receive a payment of $1.00 in cash upon the achievement of a certain milestone relating to the first sale of ELZONRIS in any one of certain countries following a marketing authorization approval by the European Commission. The CVR milestone must be achieved on or prior to December 31, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-071835","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920071835/a4.xml","form_type":"4"}},{"id":3114502,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-06-10T11:18:03.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents previously-granted performance-based awards that became vested under the agreement and plan of merger among Issuer, Berlin-Chemie AG, and Mercury Merger Sub, Inc., dated as of May 3, 2020 (the \"Merger Agreement\")."}],"balance_after":1374352,"source":{"system":"sec-edgar","filing":"0001104659-20-071835","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920071835/a4.xml","form_type":"4"}},{"id":3210738,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-03-13T21:31:51.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":16704,"price":4.91,"value":82016.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of 32,867 shares on March 9, 2020, a total of 16,704 of such shares were sold by the Company on March 10, 2020 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The range of prices for the shares sold on March 10, 2020 was $4.67 to $5.03. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Of the listed shares, 373,285 shares are restricted stock."}],"balance_after":771764,"source":{"system":"sec-edgar","filing":"0001104659-20-033491","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920033491/a4.xml","form_type":"4"}},{"id":3210737,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-03-13T21:31:51.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":9487,"price":5.08,"value":48193.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 17,576 shares on March 8, 2020, a total of 9,487 of such shares were sold by the Company on March 9, 2020 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on March 9, 2020 was $5.00 to $5.22. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 406,152 shares are restricted stock."}],"balance_after":788468,"source":{"system":"sec-edgar","filing":"0001104659-20-033491","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920033491/a4.xml","form_type":"4"}},{"id":3240972,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-02-28T21:31:40.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":11547,"price":6.42,"value":74131.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 21,996 shares on February 24, 2020, a total of 11,547 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on February 25, 2020 was $6.26 to $6.67. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 423,728 shares are restricted stock."}],"balance_after":797955,"source":{"system":"sec-edgar","filing":"0001104659-20-027397","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920027397/a4.xml","form_type":"4"}},{"id":3270260,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-14T21:32:07.000Z","date":"2019-06-12","kind":"gift","acquired":false,"shares":132176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options to purchase shares of common stock that vested 25% per year on each of the first four anniversaries of the grant date. All options have a 10-year life."}],"balance_after":0,"derivative":{"exercise_price":4.12,"expiration_date":"2026-02-24","underlying":"Common Stock","underlying_shares":132176},"source":{"system":"sec-edgar","filing":"0001104659-20-022141","document":"a5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920022141/a5.xml","form_type":"5"}},{"id":3270259,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-14T21:32:07.000Z","date":"2019-06-12","kind":"gift","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options to purchase shares of common stock that vested in three equal installments on each of the first three anniversaries of the January 7, 2016 grant date."}],"balance_after":0,"derivative":{"exercise_price":5.77,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-20-022141","document":"a5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920022141/a5.xml","form_type":"5"}},{"id":3270258,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-14T21:32:07.000Z","date":"2019-06-12","kind":"gift","acquired":false,"shares":97580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options to purchase shares of common stock that vested 25% on the first anniversary and the remaining 75% vested quarterly over a three-year period."}],"balance_after":0,"derivative":{"exercise_price":3.3,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":97580},"source":{"system":"sec-edgar","filing":"0001104659-20-022141","document":"a5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920022141/a5.xml","form_type":"5"}},{"id":3270257,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-14T21:32:07.000Z","date":"2019-06-12","kind":"gift","acquired":false,"shares":18070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust."}],"balance_after":0,"derivative":{"exercise_price":2.92,"exercise_date":"2013-01-29","expiration_date":"2021-03-08","underlying":"Common Stock","underlying_shares":18070},"source":{"system":"sec-edgar","filing":"0001104659-20-022141","document":"a5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920022141/a5.xml","form_type":"5"}},{"id":3270256,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-14T21:32:07.000Z","date":"2019-06-12","kind":"gift","acquired":false,"shares":18070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 12, 2019, options to purchase shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Hoberman's minor children. Mr. Hoberman is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options to purchase shares of common stock that vested 25% per year on each of the first four anniversaries of the grant date. All options have a 10-year life."}],"balance_after":0,"derivative":{"exercise_price":2.92,"expiration_date":"2021-03-08","underlying":"Common Stock","underlying_shares":18070},"source":{"system":"sec-edgar","filing":"0001104659-20-022141","document":"a5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920022141/a5.xml","form_type":"5"}},{"id":3270255,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-02-14T21:29:22.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":208417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 208,417 restricted shares will vest in three installments as follows: 69,473 shares on April 14, 2021; 69,472 shares on March 30, 2022; and 69,472 shares on January 18, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the listed shares, 445,724 shares are restricted stock."}],"balance_after":809502,"source":{"system":"sec-edgar","filing":"0001104659-20-022140","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920022140/a4.xml","form_type":"4"}},{"id":3302755,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-24T21:31:37.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":22139,"price":7.02,"value":155415.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 45,024 shares on January 21, 2020, a total of 22,139 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on January 22, 2020 was $6.98 to $7.05. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 237,307 shares are restricted stock."}],"balance_after":601085,"source":{"system":"sec-edgar","filing":"0001104659-20-006882","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920006882/a4.xml","form_type":"4"}},{"id":3313193,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-10T21:16:30.000Z","date":"2020-01-08","kind":"sale","acquired":false,"shares":13228,"price":10.37,"value":137174.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 25,000 shares on January 7, 2020, a total of 13,228 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on January 8, 2020 was $10.29 to $10.52. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 282,331 shares are restricted stock."}],"balance_after":623224,"source":{"system":"sec-edgar","filing":"0001104659-20-003149","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920003149/a4.xml","form_type":"4"}},{"id":3322304,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-03T17:19:02.000Z","date":"2019-12-27","kind":"sale","acquired":false,"shares":2022,"price":10.48,"value":21190.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 94,304 shares on December 21, 2019, a total of 46,312 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. 4,319 shares were sold on December 23, 2019; 24,477 shares were sold on December 24, 2019; 15,494 shares were sold on December 26, 2019; and 2,022 shares were sold on December 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on December 23, 2019 was $10.37 to $10.75; the range of prices for the shares sold on December 24, 2019 was $10.81 to $11.15; the range of prices for the shares sold on December 26, 2019 was $10.52 to $11.20; and the range of prices for the shares sold on December 27, 2019 was $10.34 to $10.76.  The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 307,331 shares are restricted stock."}],"balance_after":636452,"source":{"system":"sec-edgar","filing":"0001104659-20-000980","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/a4.xml","form_type":"4"}},{"id":3322303,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-03T17:19:02.000Z","date":"2019-12-26","kind":"sale","acquired":false,"shares":15494,"price":10.75,"value":166560.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 94,304 shares on December 21, 2019, a total of 46,312 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. 4,319 shares were sold on December 23, 2019; 24,477 shares were sold on December 24, 2019; 15,494 shares were sold on December 26, 2019; and 2,022 shares were sold on December 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on December 23, 2019 was $10.37 to $10.75; the range of prices for the shares sold on December 24, 2019 was $10.81 to $11.15; the range of prices for the shares sold on December 26, 2019 was $10.52 to $11.20; and the range of prices for the shares sold on December 27, 2019 was $10.34 to $10.76.  The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 307,331 shares are restricted stock."}],"balance_after":638474,"source":{"system":"sec-edgar","filing":"0001104659-20-000980","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/a4.xml","form_type":"4"}},{"id":3322302,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-03T17:19:02.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":24477,"price":10.97,"value":268512.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 94,304 shares on December 21, 2019, a total of 46,312 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. 4,319 shares were sold on December 23, 2019; 24,477 shares were sold on December 24, 2019; 15,494 shares were sold on December 26, 2019; and 2,022 shares were sold on December 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on December 23, 2019 was $10.37 to $10.75; the range of prices for the shares sold on December 24, 2019 was $10.81 to $11.15; the range of prices for the shares sold on December 26, 2019 was $10.52 to $11.20; and the range of prices for the shares sold on December 27, 2019 was $10.34 to $10.76.  The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 307,331 shares are restricted stock."}],"balance_after":653968,"source":{"system":"sec-edgar","filing":"0001104659-20-000980","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/a4.xml","form_type":"4"}},{"id":3322301,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-03T17:19:02.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":4319,"price":10.58,"value":45695.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 94,304 shares on December 21, 2019, a total of 46,312 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. 4,319 shares were sold on December 23, 2019; 24,477 shares were sold on December 24, 2019; 15,494 shares were sold on December 26, 2019; and 2,022 shares were sold on December 27, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for the shares sold on December 23, 2019 was $10.37 to $10.75; the range of prices for the shares sold on December 24, 2019 was $10.81 to $11.15; the range of prices for the shares sold on December 26, 2019 was $10.52 to $11.20; and the range of prices for the shares sold on December 27, 2019 was $10.34 to $10.76.  The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the listed shares, 307,331 shares are restricted stock."}],"balance_after":678445,"source":{"system":"sec-edgar","filing":"0001104659-20-000980","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465920000980/a4.xml","form_type":"4"}},{"id":3411216,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-09-18T21:11:16.000Z","date":"2019-09-17","kind":"grant","acquired":true,"shares":27048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 13, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":143953,"source":{"system":"sec-edgar","filing":"0001654954-19-010891","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/section16.xml","form_type":"4"}},{"id":3475936,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-06-28T17:17:25.000Z","date":"2019-06-26","kind":"sale","acquired":false,"shares":12508,"price":14.77,"value":184743.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"In connection with the vesting of 87,500 shares on June 21, 2019, a total of 12,508 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the weighted average sale price. The range of prices for such transaction is $14.55 to $15.03. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Of the 682,764 shares, 401,635 shares are restricted stock."}],"balance_after":682764,"source":{"system":"sec-edgar","filing":"0001104659-19-038310","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919038310/a4.xml","form_type":"4"}},{"id":3475935,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-06-28T17:17:25.000Z","date":"2019-06-25","kind":"sale","acquired":false,"shares":25500,"price":15.07,"value":384285.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of 87,500 shares on June 21, 2019, a total of 25,500 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The range of prices for such transaction is $14.64 to $15.28. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Of the 695,272 shares, 401,635 shares are restricted stock."}],"balance_after":695272,"source":{"system":"sec-edgar","filing":"0001104659-19-038310","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919038310/a4.xml","form_type":"4"}},{"id":3475934,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-06-28T17:17:25.000Z","date":"2019-06-24","kind":"sale","acquired":false,"shares":9107,"price":15.49,"value":141067.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 87,500 shares on June 21, 2019, a total of 9,107 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $14.83 to $15.79. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 720,772 shares, 401,635 shares are restricted stock."}],"balance_after":720772,"source":{"system":"sec-edgar","filing":"0001104659-19-038310","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919038310/a4.xml","form_type":"4"}},{"id":3520449,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-05-17T21:29:03.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":25817,"price":14.27,"value":368408.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 50,000 shares on May 13, 2019, a total of 25,817 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $14.15 to $14.53. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 729,879 shares, 489,135 shares are restricted stock."}],"balance_after":729879,"source":{"system":"sec-edgar","filing":"0001104659-19-030357","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919030357/a4.xml","form_type":"4"}},{"id":3592488,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-15T21:00:54.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":981,"price":11.04,"value":10830.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 17,576 shares on March 8, 2019 and 32,867 shares on March 9, 2019, a total of 26,082 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The range of prices for such transaction is $11.02 to $11.25. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Of the 755,696 shares, 539,135 shares are restricted stock."}],"balance_after":755696,"source":{"system":"sec-edgar","filing":"0001104659-19-015344","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919015344/a4.xml","form_type":"4"}},{"id":3592487,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-15T21:00:54.000Z","date":"2019-03-11","kind":"sale","acquired":false,"shares":25101,"price":11.11,"value":278872.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 17,576 shares on March 8, 2019 and 32,867 shares on March 9, 2019, a total of 26,082 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $11.00 to $11.52. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 756,677 shares, 539,135 shares are restricted stock."}],"balance_after":756677,"source":{"system":"sec-edgar","filing":"0001104659-19-015344","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919015344/a4.xml","form_type":"4"}},{"id":3603884,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-08T21:31:21.000Z","date":"2019-03-07","kind":"sale","acquired":false,"shares":2995,"price":11.36,"value":34023.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 6,094 shares on March 6, 2019, a total of 2,995 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $11.23 to $11.54. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 781,778 shares, 589,578 shares are restricted stock."}],"balance_after":781778,"source":{"system":"sec-edgar","filing":"0001104659-19-013684","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919013684/a4.xml","form_type":"4"}},{"id":3628745,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-27T21:10:01.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":10557,"price":12.05,"value":127211.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 21,996 shares on February 24, 2019, a total of 10,557 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $12.04 to $12.05. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 784,773 shares, 595,672 shares are restricted stock."}],"balance_after":784773,"source":{"system":"sec-edgar","filing":"0001104659-19-011257","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919011257/a4.xml","form_type":"4"}},{"id":3667873,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-08T20:54:16.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":13607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The 13,607 restricted shares will vest in two installments as follows: 6,804 shares on December 21, 2019 and 6,803 shares on December 21, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Of the 795,330 shares, 617,668 shares are restricted stock."}],"balance_after":795330,"source":{"system":"sec-edgar","filing":"0001104659-19-006898","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919006898/a4.xml","form_type":"4"}},{"id":3667872,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-08T20:54:16.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":135071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 135,071 restricted shares will vest in three installments as follows: 45,024 shares on January 21, 2020; 45,024 shares on April 13, 2021; and 45,023 shares on March 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the 781,723 shares, 604,061 shares are restricted stock."}],"balance_after":781723,"source":{"system":"sec-edgar","filing":"0001104659-19-006898","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919006898/a4.xml","form_type":"4"}},{"id":3697149,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-11T21:30:42.000Z","date":"2019-01-08","kind":"sale","acquired":false,"shares":13547,"price":10.15,"value":137502.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 25,000 shares on January 8, 2019, a total of 13,547 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $9.94 to $10.26. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 646,652 shares, 468,990 shares are restricted stock."}],"balance_after":646652,"source":{"system":"sec-edgar","filing":"0001104659-19-001650","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465919001650/a4.xml","form_type":"4"}},{"id":3747424,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-11-30T20:59:38.000Z","date":"2018-11-26","kind":"sale","acquired":false,"shares":26296,"price":11.85,"value":311607.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 50,000 shares on November 13, 2018, a total of 26,296 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $11.65 to $12.10. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 659,738 shares, 493,990 shares are restricted stock."}],"balance_after":659738,"source":{"system":"sec-edgar","filing":"0001104659-18-070899","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918070899/a4.xml","form_type":"4"}},{"id":3815333,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-09-14T21:58:37.000Z","date":"2018-09-12","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In the event the U.S. Food and Drug Administration approves of the Company's Biologics License Application with respect to ELZONRIS (the \"Approval Milestone\"), 87,500 shares will vest six months following the achievement of the Approval Milestone and 87,500 shares will vest on the first anniversary of the achievement of the Approval Milestone.  Or, such shares will vest as follows: 58,334 restricted shares on September 12, 2021, and 58,333 restricted shares on each of September 12, 2022 and September 12, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 684,594 shares, 543,990 shares are restricted stock."}],"balance_after":686034,"source":{"system":"sec-edgar","filing":"0001104659-18-056986","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918056986/a4.xml","form_type":"4"}},{"id":3815332,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-09-14T21:58:37.000Z","date":"2018-09-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 100,000 restricted shares will vest in two installments as follows: 50,000 shares will vest on November 13, 2018 and 50,000 shares will vest on May 13, 2019."}],"balance_after":511034,"source":{"system":"sec-edgar","filing":"0001104659-18-056986","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918056986/a4.xml","form_type":"4"}},{"id":3881653,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-06-28T21:00:32.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 26, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":116905,"source":{"system":"sec-edgar","filing":"0001654954-18-007121","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/section16.xml","form_type":"4"}},{"id":3996120,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-14T21:30:44.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":12746,"price":16.82,"value":214387.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"In connection with the vesting of 25,000 shares on March 12, 2018, a total of 12,746 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the weighted average sale price. The range of prices for such transaction is $16.55 to $17.18. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Of the 409,594 shares, 268,990 shares are restricted stock."}],"balance_after":409594,"source":{"system":"sec-edgar","filing":"0001104659-18-017586","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918017586/a4.xml","form_type":"4"}},{"id":3996119,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-14T21:30:44.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":3299,"price":18.24,"value":60173.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of 32,868 shares on March 9, 2018, a total of 3,299 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The range of prices for such transaction is $17.73 to $18.70. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Of the 422,340 shares, 293,990 shares are restricted stock."}],"balance_after":422340,"source":{"system":"sec-edgar","filing":"0001104659-18-017586","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918017586/a4.xml","form_type":"4"}},{"id":3996118,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-14T21:30:44.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":13942,"price":17.18,"value":239523.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 32,868 shares on March 9, 2018, a total of 13,942 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $16.70 to $17.70. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 425,639 shares, 293,990 shares are restricted stock."}],"balance_after":425639,"source":{"system":"sec-edgar","filing":"0001104659-18-017586","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918017586/a4.xml","form_type":"4"}},{"id":4003015,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-09T21:32:19.000Z","date":"2018-03-08","kind":"grant","acquired":true,"shares":70303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 70,303 restricted shares will vest in four installments as follows: 17,576 shares on March 8, 2019; 17,576 shares on March 8, 2020; 17,576 shares on March 8, 2021; and 17,575 shares on March 8, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Of the 439,581 shares, 326,858 shares are restricted stock."}],"balance_after":439581,"source":{"system":"sec-edgar","filing":"0001104659-18-016434","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918016434/a4.xml","form_type":"4"}},{"id":4003014,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-09T21:32:19.000Z","date":"2018-03-07","kind":"sale","acquired":false,"shares":3027,"price":16.55,"value":50096.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 6,095 shares on March 6, 2018, a total of 3,027 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $16.35 to $16.85. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 369,278 shares, 256,555 shares are restricted stock."}],"balance_after":369278,"source":{"system":"sec-edgar","filing":"0001104659-18-016434","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918016434/a4.xml","form_type":"4"}},{"id":4026806,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-02-28T21:31:50.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":5726,"price":17.26,"value":98830.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 21,996 shares on February 24, 2018, a total of 11,026 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The range of prices for such transaction is $16.95 to $17.45. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Of the 371,915 shares, 262,650 shares are restricted stock."}],"balance_after":371915,"source":{"system":"sec-edgar","filing":"0001104659-18-013695","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918013695/a4.xml","form_type":"4"}},{"id":4026805,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-02-28T21:31:50.000Z","date":"2018-02-26","kind":"sale","acquired":false,"shares":5300,"price":17.61,"value":93333.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 21,996 shares on February 24, 2018, a total of 11,026 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $17.60 to $17.75. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 377,641 shares, 262,650 shares are restricted stock."}],"balance_after":377641,"source":{"system":"sec-edgar","filing":"0001104659-18-013695","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918013695/a4.xml","form_type":"4"}},{"id":4051593,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-02-16T21:31:42.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":1851,"price":15.67,"value":29005.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 3,746 shares on February 14, 2018, a total of 1,851 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $15.60 to $15.83. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 382,941 shares, 284,646 shares are restricted stock."}],"balance_after":382941,"source":{"system":"sec-edgar","filing":"0001104659-18-010450","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918010450/a4.xml","form_type":"4"}},{"id":4100357,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-01-12T21:31:03.000Z","date":"2018-01-08","kind":"sale","acquired":false,"shares":14040,"price":13.93,"value":195577.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 25,000 shares on January 8, 2018, a total of 14,040 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $13.70 to $14.05. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 384,792 shares, 288,392 shares are restricted stock."}],"balance_after":384792,"source":{"system":"sec-edgar","filing":"0001104659-18-002137","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465918002137/a4.xml","form_type":"4"}},{"id":4126108,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-12-19T19:58:37.000Z","date":"2017-12-18","kind":"sale","acquired":false,"shares":40,"price":14.75,"value":590.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 25,000 shares on November 29, 2017, a total of 11,983 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Of the 398,832 shares, 313,392 shares are restricted stock."}],"balance_after":398832,"source":{"system":"sec-edgar","filing":"0001104659-17-074139","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917074139/a4.xml","form_type":"4"}},{"id":4126107,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-12-19T19:58:37.000Z","date":"2017-12-15","kind":"sale","acquired":false,"shares":11943,"price":14.18,"value":169351.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 25,000 shares on November 29, 2017, a total of 11,983 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $14.08 to $14.43. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 398,872 shares, 313,392 shares are restricted stock."}],"balance_after":398872,"source":{"system":"sec-edgar","filing":"0001104659-17-074139","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917074139/a4.xml","form_type":"4"}},{"id":4278009,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2017-06-19T22:10:01.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted shares that will vest on June 16, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods"}],"balance_after":101905,"source":{"system":"sec-edgar","filing":"0001654954-17-005706","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495417005706/section16.xml","form_type":"4"}},{"id":4392421,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-09T21:33:25.000Z","date":"2017-03-09","kind":"grant","acquired":true,"shares":131469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 131,469 restricted shares will vest in four installments as follows: 32,868 shares on March 9, 2018; 32,867 shares on March 9, 2019; 32,867 shares on March 9, 2020; and 32,867 shares on March 9, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Of the 409,143 shares, 338,392 shares are restricted stock."}],"balance_after":409143,"source":{"system":"sec-edgar","filing":"0001104659-17-015592","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917015592/a4.xml","form_type":"4"}},{"id":4392420,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-09T21:33:25.000Z","date":"2017-03-07","kind":"sale","acquired":false,"shares":2342,"price":8.16,"value":19110.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 6,095 shares on March 6, 2017, a total of 2,342 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $8.10 to $8.18. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 277,674 shares, 206,923 shares are restricted stock."}],"balance_after":277674,"source":{"system":"sec-edgar","filing":"0001104659-17-015592","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917015592/a4.xml","form_type":"4"}},{"id":4413661,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-01T21:53:12.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":4027,"price":7.01,"value":28229.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 21,997 shares on February 24, 2017, a total of 8,027 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The range of prices for such transaction is $6.85 to $7.20. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Of the 279,655 shares, 213,018 shares are restricted stock."}],"balance_after":279655,"source":{"system":"sec-edgar","filing":"0001104659-17-013194","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917013194/a4.xml","form_type":"4"}},{"id":4413660,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-01T21:53:12.000Z","date":"2017-02-27","kind":"sale","acquired":false,"shares":4000,"price":6.97,"value":27880.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 21,997 shares on February 24, 2017, a total of 8,027 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $6.90 to $7.03. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 283,682 shares, 213,018 shares are restricted stock."}],"balance_after":283682,"source":{"system":"sec-edgar","filing":"0001104659-17-013194","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917013194/a4.xml","form_type":"4"}},{"id":4438957,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-17T21:03:48.000Z","date":"2017-02-16","kind":"sale","acquired":false,"shares":1508,"price":6.42,"value":9681.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 3,746 shares on February 14, 2017, a total of 1,508 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such action, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $6.35 to $6.50. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 287,682 shares, 235,015 shares are restricted stock."}],"balance_after":287682,"source":{"system":"sec-edgar","filing":"0001104659-17-010293","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917010293/a4.xml","form_type":"4"}},{"id":4490941,"issuer":{"id":148550,"kind":"organization","name":"STEMLINE THERAPEUTICS INC","symbol":"STML"},"owners":[{"id":38350,"kind":"person","name":"Hoberman Kenneth","position":1,"cik":"0001573722","reported_name":"Hoberman Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-01-13T20:01:36.000Z","date":"2017-01-10","kind":"sale","acquired":false,"shares":9110,"price":13.82,"value":125900.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 25,000 shares on January 7, 2017, a total of 9,110 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such action, which was conducted automatically in accordance with the issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The range of prices for such transaction is $13.68 to $13.90. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 289,190 shares, 238,761 shares are restricted stock."}],"balance_after":289190,"source":{"system":"sec-edgar","filing":"0001104659-17-002351","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1264587/000110465917002351/a4.xml","form_type":"4"}}]}